Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.
[fabry disease]
Fabry
disease
is
an
X-
linked
lysosomal
storage
disorder
affecting
both
males
and
females
with
tremendous
genotypic
/
phenotypic
variability
.
Concentrations
of
globotriaosylceramide
(
Gb
3
)
,
globotriaosylsphingosine
(
lyso-
Gb
3
)
/
related
analogues
were
investigated
in
pediatric
and
adult
Fabry
cohorts
.
The
aims
of
this
study
were
to
transfer
and
validate
an
HPLC-
MS
/
MS
methodology
on
a
UPLC-
MS
/
MS
new
generation
platform
,
using
an
HPLC
column
,
for
urine
analysis
of
treated
and
untreated
pediatric
and
adult
Fabry
patients
,
to
establish
correlations
between
the
excretion
of
Fabry
biomarkers
with
gender
,
treatment
,
types
of
mutations
,
and
to
evaluate
the
biomarker
reliability
for
early
detection
of
pediatric
Fabry
patients
.
A
UPLC-
MS
/
MS
was
used
for
biomarker
analysis
.
Reference
values
are
presented
for
all
biomarkers
.
Results
show
that
gender
strongly
influences
the
excretion
of
each
biomarker
in
the
pediatric
Fabry
cohort
,
with
females
having
lower
urinary
levels
of
all
biomarkers
.
Urinary
distribution
of
lyso-
Gb
3
/
related
analogues
in
treated
Fabry
males
was
similar
to
the
untreated
and
treated
Fabry
female
groups
in
both
children
and
adult
cohorts
.
Children
with
the
late-onset
p
.
N
215
S
mutation
had
normal
urinary
levels
of
Gb
3
,
and
lyso-
Gb
3
but
abnormal
levels
of
related
analogues
.
In
this
study
,
Fabry
males
and
most
Fabry
females
would
have
been
diagnosed
using
the
urinary
lyso-
Gb
3
/
related
analogue
profile
.
Diseases
Validation
Diseases presenting
"abnormal levels"
symptom
alexander disease
fabry disease
krabbe disease
neonatal adrenoleukodystrophy
phenylketonuria
sneddon syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom